Charles River Laboratories has opened a new preclinical development facility in Shanghai, China which, the firm says, will act as a centre of excellence and help strengthen its position in the global outsourcing market.
Bridge Pharmaceuticals has just launched a new training scheme
between its facilities in the US and China to enable its employees
to cross train in both labs - a potential competitive advantage for
a contract research organisation...